Article Data

  • Views 2393
  • Dowloads 113

Case Reports

Open Access

Ovarian Leydig cell tumour in a postmenopausal woman with alopecia

  • A. Wesołowska1
  • A. Tuszyńska1,*,
  • K. Szlendak-Sauer1
  • R. Smolarczyk1
  • L. Grabowska-Derlatka2
  • E. Przytuła3

1Department of Gynaecological Endocrinology, Medical University of Warsaw, Warsaw, Poland

22nd Department of Clinical Radiology, Medical University of Warsaw, Poland

3Department of Pathology, Centre of Postgraduate Training, Warsaw, Poland

DOI: 10.12892/ejgo4296.2019 Vol.40,Issue 1,February 2019 pp.154-156

Accepted: 17 July 2017

Published: 10 February 2019

*Corresponding Author(s): A. Tuszyńska E-mail: agata.tuszynska@wp.pl

Abstract

Hyperandrogenism in females usually results from ovarian and/or adrenal pathology. A rapid progression of clinical manifestations, such as hirsutism, male-pattern hair loss, and clitoromegaly can strongly suggest androgen-secreting neoplasm. The authors describe a case of a postmenopausal 64-year-old woman, presented with advanced androgenic alopecia and progressive hirsutism arising over three years. The patient suffered from many internal disorders. Hormonal tests revealed high total levels of testosterone and estradiol. A solid tumour of the right ovary measuring 15×13×16 mm with strong enhancement was observed in pelvic dynamic MRI. Total abdominal hysterectomy, bilateral salpingo-oophorectomy, and partial omentectomy were performed. Histology revealed a 2.5-cm right ovary containing a 1.8-cm sized beige-yellow tumour, identified as Leydig cell ovarian tumour with positive result of inhibin staining. Postoperatively, testosterone level returned to normal with a gradual regression of clinical symptoms.

Keywords

Hyperandrogenism; Adrenal glands; Hirsutism; Ovarian Leydig cell tumour

Cite and Share

A. Wesołowska,A. Tuszyńska,K. Szlendak-Sauer,R. Smolarczyk,L. Grabowska-Derlatka,E. Przytuła. Ovarian Leydig cell tumour in a postmenopausal woman with alopecia. European Journal of Gynaecological Oncology. 2019. 40(1);154-156.

References

[1] Fogle R.H., Stanczyk F.Z., Zhang X., Paulson R.J.: “Ovarian androgen production in postmenopausal women”. J. Clin. Endocrinol. Metab., 2007, 92, 3040.

[2] Alpañés M., González-Casbas J.M., Sánchez J., Pián H., Escobar-Morreale H.F.: “Management of postmenopausal virilisation”. JCEM, 2012, 97, 2584.

[3] Azziz R., Sanchez L., Knochenhauer E., Moran C., Lazenby J., Stephens K.C., et al.: “Androgen excess in women: experience with over 1000 consecutive patients”. J. Clin. Endocrinol. Metab., 2004, 89, 453.

[4] Varothai S., Bergfeld W.F.: “Androgenic alopecia: evidenced-based treatment update”. Am. J. Clin. Dermatol., 2014, 15, 217.

[5] Mirmirani P.: “Managing hair loss in midlife women”. Maturitas, 2013, 74, 119.

[6] Olt G., Mortel R.: “Hormone-producing tumors of the ovary”. Endocr. Relat. Cancer, 1997, 4, 447.

[7] Souto S.B., Baptista P.V., Braga D.C., Carvalho D.: “Ovarian Leydig cell tumor in a post-menopausal patient with severe hyperandrogenism”. Arq. Bras. Endocrinol. Metab., 2014, 58, 68.

[8] Tutzer M., Winnykamien I., Guardia J.D., Castel-Branco C.: “Hyperandrogenism in post-menopausal women: a diagnosis challenge”. Gynecol. Endocrinol., 2014, 30, 23.

[9] Koeneman M.M., Heiligers-Duckers C., van der Velde R., Wouda S., de Rooij M.J., Janssen M.J., Boskamp D.: “Ovarian Leydig cell hyperplasia as a rare cause of hair loss in a postmenopausal female patient: a case report and diagnostic approach toward post-menopausal hyperandrogenism”. Eur. J. Obstet. Gynecol. Reprod., Biol., 2016, 199, 198.

Submission Turnaround Time

Top